Aura Biosciences

About Us
Our Science
Clinical Programs
News and Publications
Careers
Contact Us

Aura Biosciences

10_Lab stil lifes_Genevieve de Manio Photgraphy.jpg

News & Publications

News & Publications

  • In the News
  • Press Releases
  • Publications

The Ophthalmologist - A Job for Life (Sitting down with . . . Carol Shields)

October 9, 2018
David Rosen

The Ophthalmologist

Oct 9, 2018
David Rosen

Ophthalmology Times - Targeted therapy for ocular melanoma

August 23, 2018
lisa raffensperger

Ophthalmology Times

Aug 23, 2018
lisa raffensperger

Retina Specialist - Moving the Needle on Ocular Cancer

March 30, 2018
lisa raffensperger

Retina Specialist

Mar 30, 2018
lisa raffensperger

The Ophthalmologist - Red Light Means Go? A recent trial shows promise for a new ocular melanoma therapeutic

December 20, 2017
Aura Biosciences

The Ophthalmologist

Dec 20, 2017
Aura Biosciences

Modern Retina - Tumor-targeted therapy changing game for choroidal melanoma

November 11, 2017
Aura Biosciences

Modern Retina

Nov 11, 2017
Aura Biosciences

NIH - NCI’s Douglas R. Lowy and John T. Schiller to receive 2017 Lasker Award

September 8, 2017
Matthew Zola

National Institutes of Health

Sep 8, 2017
Matthew Zola

EyewireTV - Ocular Melanoma Trial; Hepatitis C Link to Cataracts

April 5, 2017
Aura Biosciences

Eyewire Today

Apr 5, 2017
Aura Biosciences

Innovation in Retina: Aura Biosciences Seeks to Cure Ocular Melanoma

April 1, 2017
Aura Biosciences

Retinal Physician

Apr 1, 2017
Aura Biosciences

FDA fast tracks ocular melanoma treatment

March 30, 2017
Aura Biosciences

American Academy of Ophthalmology

Mar 30, 2017
Aura Biosciences

Potential Breakthrough Therapy For People With Common Form Of Eye Cancer

March 30, 2017
Aura Biosciences

CBS Philly

Mar 30, 2017
Aura Biosciences

MassBio Winter 2016 Newsletter:
A Patient’s Desire to Help

February 25, 2016
D&CO

Laabs’ foundation and Aura Biosciences advance efforts to develop new and better therapies to treat rare cancer patients. Aura Biosciences is hoping to improve the options for future ocular melanoma patients.

Feb 25, 2016
D&CO

PODCAST: Aura Biosciences Offers Hope for Ocular Melanoma

November 24, 2015
D&CO

Listen to this podcast to learn more about how Aura CEO Eli de los Pinos built the company from the ground up around viral-like synthetic nanoparticles that are closely related to wild type viruses in structure and behavior but lack any viral DNA.

Nov 24, 2015
D&CO

Aura Biosciences CEO Elisabet de los Pinos to Present at 2015 OIS@AAO Conference

November 12, 2015
D&CO

Las Vegas

Nov 12, 2015
D&CO

Aura Biosciences CEO Elisabet de los Pinos to Present at the Ocular Melanoma Foundation's 2015 Patient Retreat

October 16, 2015
D&CO

Cleveland Clinic

Oct 16, 2015
D&CO

Aura Biosciences Wants to Treat Eye Cancer and Save Patients’ Vision

March 5, 2015
D&CO

Wall Street Journal

Mar 5, 2015
D&CO

Aura Biosciences CEO Elisabet de los Pinos to present at East/West Conference

January 11, 2014
D&CO

JP Morgan, San Francisco

Jan 11, 2014
D&CO

Aura Biosciences CEO Elisabet de los Pinos to present at Cancer Advance Conference

September 19, 2013
D&CO

Harvard Medical School

Sep 19, 2013
D&CO

Former Genzyme Prez Joins $3.2M Round for Aura Biosciences

December 27, 2012
D&CO

Boston Business Journal

Dec 27, 2012
D&CO

Nanotech treatments could attack tumour cells without side effects

February 15, 2012
D&CO

wired.co.uk

Feb 15, 2012
D&CO

Fast Company: Women-Run Startups to Watch

February 23, 2011
D&CO

Fast Company

Feb 23, 2011
D&CO
Older Posts
Back to Top
  • About Us
  • Our Science
  • Clinical Programs
  • News and Publications
  • Careers
  • Contact Us
  • Copyright © 2017
  • Aura Biosciences, Inc.
  • 85 Bolton Street
  • Cambridge, MA 02140